Public Calendar: January 16-22, 2022
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Janet Woodcock, M.D., Acting Commissioner
Event Date: 01/19/2022
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines
Event Date: 01/21/2022
Location: Virtual
Subject: The George Washington University; Panelist: FDA-Patent and Trademark Office Roundtable
FDA Participant/Group: GRAIL SIPES; MARYLL TOUFANIAN;
Non FDA Participant/Group: Government, industry, academia, and other registered guests
Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 01/18/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: RAM IYER; DONALD PRATER;
Non FDA Participant/Group: Alex Kozak, Elliott Grant (X Company);
Event Date: 01/18/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Mariann Kirkerod, Odd Medhus (Aquatiq);
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Erica Jefferson, Associate Commissioner for External Affairs
No Significant Event
Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
Event Date: 01/18/2022
Location: Virtual
Subject: International Coalition of Medicines Regulatory Authorities (ICMRA) Executive Committee Meeting
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: ICMRA Executive Committee members
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 01/19/2022
Location: Virtual
Subject: National Foundation for Infectious Diseases (NFID) Webinar; COVID-19: Myths and Facts
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the National Foundation for Infectious Diseases (NFID) Webinar: COVID-19: Myths and Facts
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event